In the United States, the procedure implemented by the Food and Drug Administration (FDA) for reviewing applications for nicotine pouch market authorization is experiencing a slowdown. Several consistent sources, including Reuters, have reported that some cases involving widely distributed products have not been finalized within the originally anticipated time frame due to ongoing uncertainties regarding the robustness of available scientific data and potential effects on nicotine initiation, especially among young people and non-users. This development comes amidst a surge in the U.S. nicotine pouch market and increased debates on the conditions of their regulatory oversight.
A rigorous procedure faced with public health requirements
The FDA initiated a pilot program in September 2025 to accelerate the review of certain authorization requests while maintaining the scientific criteria of the tobacco product pre-market procedure. A first set of decisions was made in December 2025 with the approval of six products presented as part of this review process. However, several cases examined under this framework did not yield expected outcomes. The evidence provided by manufacturers is considered insufficient at this stage to establish a clear public health benefit. Concerns primarily revolve around the appeal of these products to young people and the potential for initiation among non-nicotine users.
According to American legal framework, the FDA bases its decisions on an overall product evaluation, which must be “appropriate for public health protection.” This approach involves weighing potential benefits for smokers against risks of expanding use to new demographics. The agency emphasizes the highly addictive nature of nicotine and its impact on the brain development of young individuals.
A rapidly expanding market under regulatory scrutiny
This slowdown occurs within the context of a significant rise in nicotine pouches in the U.S., now identified as the fastest-growing segment among nicotine products. The noncombustible tobacco alternatives market is estimated at around $22 billion, with sales volumes experiencing substantial growth. For example, in 2025, over 794 million ZYN boxes were sold in the U.S., more than double the sales recorded in 2023.
This momentum underscores the strategic importance of these products for manufacturers, for whom swift market access is a key competitiveness and profit issue. This growth also puts increased pressure on regulatory authorities. Some adjustments in the pilot program, such as using generalized data rather than specific studies for each product, have generated criticisms regarding their ability to address differences in composition, dosage, or flavors that could influence usage behaviors.
The risk of youth initiation at the forefront of concerns
The dissemination of nicotine pouches among young people poses a central vigilance point. Data from the National Youth Tobacco Survey shows that current use of these products among American students rose from 1.5% in 2023 to 1.8% in 2024, involving nearly half a million young users. Over one-fifth of them report daily usage, with certain brands being significantly dominant.
While these levels remain lower than those observed for other products, their increasing trend combined with aggressive marketing strategies fuels public health actors’ worries. During the review process, some experts point out that expected benefits for smokers are not sufficiently substantiated in terms of initiation risks, including among young adults.
This analysis leads the FDA to adopt a cautious approach, emphasizing that potential risk reduction gains require complete tobacco replacement, not simultaneous use or spread to non-nicotine users. Beyond solely comparing risk reduction to cigarettes, the evaluation focuses on the overall impact of these products on consumption behaviors and public health as a whole. The observed hesitations reflect a growing concern: preventing products marketed by manufacturers as tobacco alternatives from actually contributing to the emergence of new forms of nicotine addiction.
Generation Without Tobacco
[1] Emma Rumney, Patrick Wingrove, Exclusive: US nicotine pouch fast-track scheme slowed by worries over youth, new users, Reuters, published on April 1, 2026, accessed on the same day.
